The specific functions of dopamine D 2 receptor-positive (D 2 R) striatopallidal neurons remain poorly understood. Using a genetic mouse model, we found that ablation of D 2 R neurons in the entire striatum induced hyperlocomotion, whereas ablation in the ventral striatum increased amphetamine conditioned place preference. Thus D 2 R striatopallidal neurons limit both locomotion and, unexpectedly, drug reinforcement.
The specific functions of dopamine D 2 receptor-positive (D 2 R) striatopallidal neurons remain poorly understood. Using a genetic mouse model, we found that ablation of D 2 R neurons in the entire striatum induced hyperlocomotion, whereas ablation in the ventral striatum increased amphetamine conditioned place preference. Thus D 2 R striatopallidal neurons limit both locomotion and, unexpectedly, drug reinforcement.
The striatum is critically involved in motor and motivational functions 1, 2 . The dorsal striatum, caudate-putamen, is primarily implicated in motor control and the learning of habits and skills, whereas the ventral striatum, the nucleus accumbens (NAc), is essential for motivation and drug reinforcement 1, 3 . Striatal dysfunction has been demonstrated in movement disorders, including Parkinson's and Huntington's disease, and in psychiatric disorders, such as schizophrenia and drug addiction 4 .
The GABA medium-sized spiny neurons (MSNs, about 95% of striatal neurons), which are targets of the cerebral cortex and the midbrain dopaminergic neurons, form two pathways 5 . The dopamine D 1 receptor-positive (D 1 R) striatonigral MSNs project to the medial globus pallidus and substantia nigra pars reticulata (direct pathway) and coexpress dopamine D 1 receptors and substance P, whereas D 2 R striatopallidal MSNs project to the lateral globus pallidus (indirect pathway) and coexpress dopamine D 2 receptor, adenosine A 2A receptor (A 2A R) and enkephalin (Enk). The specific role of the two efferent pathways in motor and motivational control remains poorly understood. D 1 R striatonigral and D 2 R striatopallidal neurons, which are intermingled and morphologically indistinguishable, cannot be functionally dissociated with techniques such as chemical lesions or surgery and the currently available tools for selective targeting of these populations are unsatisfactory. The Drd1a-and Drd2-egfp transgenic mice obtained by BAC transgenesis 6 have recently shed some light on the role of MSN subpopulations or genes in striatal pathophysiology [7] [8] [9] [10] . In regards to their role in motivation and drug addiction, current studies are focused mostly on the D 1 R striatonigral neurons 2 .
To assess the role of D 2 R striatopallidal neurons, we selectively ablated these cells in adult mice by Cre-mediated expression of a diphtheria toxin receptor (DTR) and diphtheria toxin injection 11 (Supplementary Methods online). All animal procedures were approved by the Université Libre de Bruxelles School of Medicine Ethical Committee. We generated mice expressing Cre recombinase under the control of the Adora2a (A 2A R) promoter (Adora2a-cre mice, Supplementary Fig. 1 online) by BAC transgenesis. A 2A R was chosen because it is expressed more in D 2 R neurons than in any other brain area 12 and, in contrast to D 2 R, A 2A R is supposed to not be expressed in striatal cholinergic interneurons and mesostriatal dopaminergic cells. In Adora2a-cre mice mated with a Rosa26-LacZ reporter strain, b-galactosidase staining was only found in striatal Enk-positive cells ( Supplementary Fig. 1 ), indicating that Cre was selectively expressed in D 2 R striatopallidal neurons.
Adora2a-cre mice were crossed with mice in which the expression of a simian DTR (Hbegf ) gene from a ubiquitously active promoter is prevented by a loxP-flanked stop cassette (inducible DTR mice, iDTR) 11 , leading to double transgenic Adora2a-cre/+; iDTR/+ mice (DTR-positive mice) that selectively expressed DTR in D 2 R striatopallidal neurons ( Supplementary Fig. 2 online) . Toxin was stereotaxically injected into the striatum to produce unilateral or bilateral ablation of D 2 R neurons in the entire striatum (full ablation) or in the NAc (NAc ablation). We analyzed the kinetics of D 2 R striatopallidal ablation in DTR-positive mice with unilateral striatum diphtheria toxin injections by quantifying A 2A R binding sites from 3-28 d after diphtheria toxin injections (Fig. 1a-c) . The injected side showed a 65% and 45% reduction in A 2A R binding in the dorsal and ventral striatum, respectively, at 7 d after injections, and an almost complete loss of striatal A 2A R binding (97% in dorsal and 87% in ventral striatum) from 14 d after diphtheria toxin injections, with no reduction in striatonigral neuron-specific D 1 R binding (Fig. 1a-c) . We found no changes in binding sites in diphtheria toxin-injected control littermates lacking DTR expression (Adora2a-cre -/-; iDTR/+; DTR negative mice) or in saline-injected DTR-positive mice. The disappearance of D 2 R striatopallidal neuron mRNAs (D 2 R, A 2A R and Enk) and the preservation of D 1 R striatonigral neuron mRNAs (D 1 R and substance P) on the injected side at 14 d after injections (Fig. 1d,e) confirmed the specificity of the lesion. The same pattern of ablation was detected from the anterior to the posterior striatum ( Supplementary Fig. 3 online) . The four subpopulations of striatal interneurons remained intact ( Supplementary Fig. 4 online) .
In light of the connections between midbrain dopamine and striatal neurons, we investigated the consequences of D 2 R striatopallidal neuron loss on the mesostriatal dopamine system. Bilateral full ablation of D 2 R striatopallidal neurons did not modify cell body or terminal dopaminergic markers ( Supplementary Fig. 5 online) . To assess dopaminergic function in vivo, we carried out intrastriatal microdialysis in bilateral diphtheria toxin-injected DTR-positive and DTR-negative mice. No difference in basal dopamine extracellular concentration or in amphetamine (AMPH)-induced dopamine overflow was found between the two genotypes ( Supplementary  Fig. 5 ). These results indicate that D 2 R striatopallidal neuron ablation does not induce major modifications in striatal dopaminergic function.
As D 2 R neurons send GABAergic projections to GABA neurons of the globus pallidus, we assessed the effect of bilateral D 2 R neuron loss on glutamic acid decarboxylase isoform 67 mRNA levels in the globus pallidus as an indirect index of GABA neuron activity 13 (Supplementary Fig. 6 online) . We found an increase in glutamic acid decarboxylase isoform 67 mRNA in the globus pallidus of DTR-positive mice as compared with DTR-negative mice, confirming that the D 2 R striatopallidal neurons exert inhibitory control on globus pallidus GABA neuron activity.
Locomotor activity in open field boxes was recorded daily for 30 min (Fig. 2 ) in mice that underwent bilateral full striatum diphtheria toxin injections. Starting at 6 d after diphtheria toxin injections, DTRpositive mice became threefold to fourfold more active than controls (Supplementary Video 1 online). This hyperactivity was stable through day 16 (Fig. 2c) and DTR-positive mice were still hyperactive (207 ± 19% of control level) 33 d after diphtheria toxin injection (data not shown). These results demonstrate the inhibitory function of the D 2 R striatopallidal neurons on locomotor activity.
As the ventral striatum is the key neuronal substrate for drug reinforcement 3 , we carried out a NAc D 2 R striatopallidal neuron ablation in DTR-positive mice (Fig. 2d,e) . Enk mRNA levels in the ventral striatum of diphtheria toxin-injected DTR-positive mice decreased by 80% compared with control diphtheria toxin-injected DTR-negative mice. We found a 30% reduction in Enk mRNA in the dorsal striatum, selectively in its rostral part. Because dorsal striatum shows progressive rostro-caudal enlargement, this limited rostral loss modestly influenced the overall number of D 2 R striatopallidal neurons in the dorsal striatum. NAc ablation did not show spontaneous hyperlocomotion ( Supplementary Fig. 7 online) , demonstrating that the NAc ablation of D 2 R striatopallidal neurons is functionally different from the full ablation. NAc DTR-positive mice were examined in an AMPH (1, 3 or 5 mg per kg) conditioned place preference (CPP) procedure followed by an examination of CPP extinction over 1 week (Fig. 2f) . The DTR-positive mice showed a higher preference for the AMPH-paired compartment as compared with controls on the first test day (2 d after the last AMPH injection) and maintained greater CPP on the following test days (4 and 9 d after last AMPH injection) (see Supplementary Methods for statistical analyses). Note that there was a loss of CPP for DTR-negative mice on day 9 (AMPH 1 and 3 mg per kg), whereas DTR-positive mice still showed a preference for the AMPH-paired compartment.
In summary, our results provide direct experimental evidence that D 2 R striatopallidal neurons are critical for both the control of motor behavior and drug reinforcement. The Adora2a-cre/+; iDTR/+ mouse, allowing specific D 2 R striatopallidal neuron ablation, confirmed that mechanisms. The complete bilateral ablation of these neurons induces persistent spontaneous hyperlocomotion, demonstrating a functional effect of D 2 R striatopallidal neuron loss and validating the hypothesis that A 2A R-D 2 R-expressing neurons normally inhibit motor activity 1 . The increase in AMPH CPP following ablation of D 2 R striatopallidal neurons mainly in the NAc was unanticipated and is, to the best of our knowledge, the first experimental demonstration that the pathway in which these neurons take part normally inhibits drug reinforcement. These data suggest that, similar to what has been observed for motor control, reciprocal antagonism between D 2 R striatopallidal and D 1 R striatonigral neurons is crucial for motivational processes and reinforcement. The involvement of D 2 Rs in drug reward processes is still puzzling 15 , as D 2 Rs are expressed at many sites in the striatal network. Our results suggest that the activation of postsynaptic D 2 Rs on D 2 R striatopallidal neurons in the NAc facilitates drug reinforcement by inhibiting these neurons 4, 15 .
Together, these data show that Adora2a-cre/+; iDTR/+ mice are a useful movement disorder model and underscore the need for characterization of the specific cellular and molecular modifications that are induced in D 2 R striatopallidal neurons by drugs of abuse.
Note: Supplementary information is available on the Nature Neuroscience website. 
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